BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Zeng DW, Dong J, Liu YR, Jiang JJ, Zhu YY. Noninvasive models for assessment of liver fibrosis in patients with chronic hepatitis B virus infection. World J Gastroenterol 2016; 22(29): 6663-6672 [PMID: 27547009 DOI: 10.3748/wjg.v22.i29.6663]
URL: https://www.wjgnet.com/1007-9327/full/v22/i29/6663.htm
Number Citing Articles
1
Minjie Jiang, Xin Yan, Xinyue Song, Qi Yan, Youyou Zhao, Luyuan Wang, Pujun Gao. Total bile acid to platelet ratioMedicine 2020; 99(22): e20502 doi: 10.1097/MD.0000000000020502
2
Ju‐Seop Kang, Min‐Ho Lee. Liver Cirrhosis - Update and Current Challenges2017;  doi: 10.5772/intechopen.68317
3
Robert J. Wong, Angelica Le, My T. Nguyen, Huy N. Trinh, Andrew Huynh, My Tops Ly, Huy A. Nguyen, Khanh K. Nguyen, Jenny Yang, Ruel T. Garcia, Brian Levitt, Eduardo da Silveira, Robert G. Gish. Significant Hepatic Fibrosis Among Treatment-Naive Chronic Hepatitis B Virus With Increased Hepatitis B Virus DNA and Normal Alanine AminotransferaseClinical Gastroenterology and Hepatology 2018; 16(1): 146 doi: 10.1016/j.cgh.2017.07.012
4
Tolga Sahin, Ayfer Serin, Ertan Emek, Birkan Bozkurt, Bahadir Turkmen Arikan, Yaman Tokat. Effectiveness of Noninvasive Fibrosis Markers for the Prediction of Hepatocellular Carcinoma in Chronic Hepatitis B and Chronic Hepatitis B+D Induced CirrhosisTransplantation Proceedings 2019; 51(7): 2397 doi: 10.1016/j.transproceed.2019.01.193
5
Yaqiong Chen, Jiao Gong, Wenying Zhou, Yusheng Jie, Zhaoxia Li, Yutian Chong, Bo Hu. A Novel Prediction Model for Significant Liver Fibrosis in Patients with Chronic Hepatitis BBioMed Research International 2020; 2020: 1 doi: 10.1155/2020/6839137
6
Dmitry V. Garbuzenko. Diagnostic and risk stratification aspects of liver fibrosis progression in chronic hepatitis B and C viral infectionMedical Journal of the Russian Federation 2021; 27(4): 373 doi: 10.17816/0869-2106-2021-27-4-373-384
7
Mirella Fraquelli, Ilaria Fanetti, Andrea Costantino. Elastography of the Liver and Beyond2021; : 119 doi: 10.1007/978-3-030-74132-7_9
8
Maria Pokorska-Śpiewak, Barbara Kowalik-Mikołajewska, Małgorzata Aniszewska, Magdalena Pluta, Magdalena Marczyńska. Novel serum biomarkers modified by the body mass index z-score for the detection of liver fibrosis and steatosis in children with chronic hepatitis CBMC Infectious Diseases 2017; 17(1) doi: 10.1186/s12879-017-2462-1
9
Yi-Ning Dai, Yue-Xing Tu, Di Meng, Mei-Juan Chen, Jia-Jie Zhang, Yu-Han Gong, Yong-Xi Tong, Ming-Shan Wang, Hong-Ying Pan, Hai-Jun Huang. Serum Proteomic Changes as Candidate Biomarkers of Intermediate Liver Fibrosis in Chronic Hepatitis B InfectionOMICS: A Journal of Integrative Biology 2019; 23(3): 167 doi: 10.1089/omi.2018.0179
10
思妍 赵. Overview of the Therapeutic Mechanism of Liver Fibrosis Based on Hepatic Stellate CellsAdvances in Clinical Medicine 2022; 12(05): 4810 doi: 10.12677/ACM.2022.125698
11
Xingxiang Liu, Jian Zhou, Liyao Zhu, Feng Li, Xin Zhang. Diagnostic accuracy of apparent diffusion coefficient values combined with γ-glutamyl transpeptidase-to-platelet ratio parameters for predicting hepatitis B-related fibrosisClinics and Research in Hepatology and Gastroenterology 2022; : 101968 doi: 10.1016/j.clinre.2022.101968
12
Mazen Noureddin, Micaela M Wong, Tsuyoshi Todo, Shelly C Lu, Arun J Sanyal, Edward A Mena. Fatty liver in hepatitis C patients post-sustained virological response with direct-acting antiviralsWorld Journal of Gastroenterology 2018; 24(11): 1269-1277 doi: 10.3748/wjg.v24.i11.1269
13
Arshi Khanam, Paul G. Saleeb, Shyam Kottilil. Pathophysiology and Treatment Options for Hepatic Fibrosis: Can It Be Completely Cured?Cells 2021; 10(5): 1097 doi: 10.3390/cells10051097
14
D.‐P. Liu, W. Lu, Z.‐Q. Zhang, Y.‐B. Wang, R.‐R. Ding, X.‐L. Zhou, D. Huang, X.‐F. Li. Comparative evaluation of GPR versus APRI and FIB‐4 in predicting different levels of liver fibrosis of chronic hepatitis BJournal of Viral Hepatitis 2018; 25(5): 581 doi: 10.1111/jvh.12842
15
D. Liu, J. Li, W. Lu, Y. Wang, X. Zhou, D. Huang, X. Li, R. Ding, Z. Zhang. Gamma-glutamyl transpeptidase to cholinesterase and platelet ratio in predicting significant liver fibrosis and cirrhosis of chronic hepatitis BClinical Microbiology and Infection 2019; 25(4): 514.e1 doi: 10.1016/j.cmi.2018.06.002
16
Mingfa Chen, Zhiguo Wu, Zhan Du, Shuilin Sun, Jun Wu, Jie Luo. Diagnostic accuracy of red blood cell distribution width to platelet ratio for predicting liver fibrosis in patients with chronic hepatitis B: A meta-analysisGastroenterología y Hepatología (English Edition) 2022; 45(5): 361 doi: 10.1016/j.gastre.2021.10.003
17
Changfei Li, Shousheng Liu, Linlin Lu, Quanjiang Dong, Shiying Xuan, Yongning Xin. Association between Serum Cytokeratin-18 Neoepitope M30 (CK-18 M30) Levels and Chronic Hepatitis B: A Meta-AnalysisHepatitis Monthly 2018; 18(4) doi: 10.5812/hepatmon.64152
18
Hee Sun Park, Won Hyeok Choe, Hye Seung Han, Mi Hye Yu, Young Jun Kim, Sung Il Jung, Jeong Han Kim, So Young Kwon. Assessing significant fibrosis using imaging-based elastography in chronic hepatitis B patients: Pilot studyWorld Journal of Gastroenterology 2019; 25(25): 3256-3267 doi: 10.3748/wjg.v25.i25.3256
19
Arshi Khanam, Joel V. Chua, Shyam Kottilil. Immunopathology of Chronic Hepatitis B Infection: Role of Innate and Adaptive Immune Response in Disease ProgressionInternational Journal of Molecular Sciences 2021; 22(11): 5497 doi: 10.3390/ijms22115497
20
Mingfa Chen, Zhiguo Wu, Zhan Du, Shuilin Sun, Jun Wu, Jie Luo. Diagnostic accuracy of red blood cell distribution width to platelet ratio for predicting liver fibrosis in patients with chronic hepatitis B: A meta-analysisGastroenterología y Hepatología 2022; 45(5): 361 doi: 10.1016/j.gastrohep.2021.10.001